Talia M. Muram

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Kenneth B. Gordon, Andrew Blauvelt, Kim Papp et al. · New England Journal of Medicine · 2016 · 838 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Ixekizumab Pharmacokinetics, Anti-Drug Antibodies, and Efficacy through 60 Weeks of Treatment of Moderate to Severe Plaque Psoriasis

Kristian Reich, Kimberley Jackson, Susan Ball et al. · Journal of Investigative Dermatology · 2018 · 53 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants

Elisa Gómez, Jessie L. Bishop, Kimberley Jackson et al. · BioDrugs · 2017 · 41 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity

Mwangi J. Murage, Amanda H. Anderson, Deborah Casso et al. · Journal of Dermatological Treatment · 2018 · 32 citations

Medicine, Dermatology, Pharmacotherapy +16

Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry

Philip J. Mease, Carol J. Etzel, William J. Huster et al. · RMD Open · 2019 · 31 citations · Full text

Medicine, Clinical Sciences, Dermatology +12